Thrombospondin-2 Modulates Extracellular Matrix Remodeling during Physiological Angiogenesis
- 30 September 2008
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 173 (3), 879-891
- https://doi.org/10.2353/ajpath.2008.080128
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (GM 072194-01)
This publication has 54 references indexed in Scilit:
- Thrombospondins Use the VLDL Receptor and a Nonapoptotic Pathway to Inhibit Cell Division in Microvascular Endothelial CellsMolecular Biology of the Cell, 2008
- Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signalingBlood, 2008
- IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbsProceedings of the National Academy of Sciences, 2007
- Thrombospondin-based antiangiogenic therapyMicrovascular Research, 2007
- Mechanisms Underlying the Impairment of Ischemia-Induced Neovascularization in Matrix Metalloproteinase 2–Deficient MiceCirculation Research, 2007
- Increasing Survival of Ischemic Tissue by Targeting CD47Circulation Research, 2007
- Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularizationJCI Insight, 2006
- Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide–mediated vascular smooth muscle relaxationBlood, 2006
- Megakaryocytes require thrombospondin-2 for normal platelet formation and functionBlood, 2003
- Generation of Monoclonal Antibodies to Cryptic Collagen Sites by Using Subtractive ImmunizationHybridoma, 2000